Molecule GEN is a biotechnology company specializing in artificial intelligence-driven solutions for drug discovery and development. The company focuses on leveraging advanced computational methods to accelerate the identification of potential therapeutic candidates, optimize drug design, and enhance the overall efficiency of the pharmaceutical research process. By integrating machine learning and data analytics, Molecule GEN aims to streamline workflows and reduce the time and cost associated with bringing new drugs to market.